Literature DB >> 15148099

Management of lentigo maligna and lentigo maligna melanoma with staged excision: a 5-year follow-up.

Jennifer L Bub1, Daniel Berg, April Slee, Peter B Odland.   

Abstract

OBJECTIVE: To assess the long-term cure rate for treatment of lentigo maligna (LM) and lentigo maligna melanoma (LMM) by means of a staged, margin-controlled, vertical-edged excision with rush permanent specimens and a radial sectioning technique.
DESIGN: Retrospective follow-up study.
SETTING: University-affiliated and private-practice dermatologic surgery clinics. PATIENTS: Fifty-nine patients treated for 55 LMs and 7 LMMs between January 1, 1990, and December 31, 2001.
INTERVENTIONS: The technique included vertical excision with initial 2- to 3-mm margins examined by rush permanent sections (prepared and read within 24 hours). Further excision took place as guided by histologic findings. Data on patient and lesion characteristics were obtained via a medical chart review. Patients were then contacted and examined for local recurrence. Biopsies were performed on all patients with possible recurrence on clinical examination. MAIN OUTCOME MEASURES: Local recurrence of LM or LMM.
RESULTS: After a mean follow-up of 57 months (median, 54 months; 293.8 person-years), 95% of patients were free of recurrence. Three patients had local recurrence and no patients had evidence of metastasis. Two of the 3 local recurrences were of previously excised LM, and 1 was of an LMM. Half (32) of all lesions required 2 or more stages. One required more than 4 stages. The average margin of excision was 0.55 cm. Three of the 58 lesions read as LM on biopsy were found to have invasive disease (LMM) at the time of definitive excision.
CONCLUSIONS: The technique described herein for the treatment of LM and LMM provides a long-term disease-free survival of 95%. The cure rate is greater than that reported for standard excision and is similar to that for other margin-control techniques. To our knowledge, this is the largest reported study and has the longest follow-up for this excision method for LM and LMM.

Entities:  

Mesh:

Year:  2004        PMID: 15148099     DOI: 10.1001/archderm.140.5.552

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  13 in total

1.  Rate of Recurrence of Lentigo Maligna Treated With Off-Label Neoadjuvant Topical Imiquimod, 5%, Cream Prior to Conservatively Staged Excision.

Authors:  Jessica M Donigan; Mark A Hyde; David E Goldgar; Michael L Hadley; Marianne Bowling; Glen M Bowen
Journal:  JAMA Dermatol       Date:  2018-08-01       Impact factor: 10.282

Review 2.  Lentigo maligna and lentigo maligna melanoma: contemporary issues in diagnosis and management.

Authors:  Karen L Connolly; Kishwer S Nehal; Klaus J Busam
Journal:  Melanoma Manag       Date:  2015-05-18

3.  Lentigo maligna melanoma with a history of cosmetic treatment: Prevalence, surgical outcomes and considerations.

Authors:  Brian P Hibler; Karen L Connolly; Erica H Lee; Anthony M Rossi; Kishwer S Nehal
Journal:  Lasers Surg Med       Date:  2017-05-29       Impact factor: 4.025

4.  Staged Excision for Lentigo Maligna and Lentigo Maligna Melanoma: Analysis of Surgical Margins and Long-term Recurrence in 68 Cases from a Single Practice.

Authors:  Joshua B Wilson; Hobart W Walling; Richard K Scupham; Andrew K Bean; Roger I Ceilley; Kirsten E Goetz
Journal:  J Clin Aesthet Dermatol       Date:  2016-06-01

5.  Re-excision within a radius of 2 cm in patients with melanoma of the skin - sufficient for local oncological radicalness.

Authors:  Strahil Asenov Strashilov; Angel Danchev Yordanov; Mariela Borisova Vasileva-Slaveva; Assia Andrianova Konsoulova
Journal:  Arch Med Sci       Date:  2020-07-08       Impact factor: 3.707

6.  Contoured technique for lentigo maligna.

Authors:  Monica Jidid Mateus; Violeta Duarte Tortelly; Carlos Baptista Barcaui; Carla Araujo Jourdan; Tassiana Simão; Juan Manuel Piñeiro Maceira
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

Review 7.  Diagnosis and management of lentigo maligna: a review.

Authors:  Julia M Kasprzak; Yaohui G Xu
Journal:  Drugs Context       Date:  2015-05-29

8.  An assessment of histological margins and recurrence of melanoma in situ.

Authors:  Kenneth M Joyce; Cormac W Joyce; Deirdre M Jones; Paul Donnellan; Alan J Hussey; Padraic J Regan; Jack L Kelly
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-03-06

9.  Recurrence Rate of Melanoma in Situ when Treated with Serial Disk Staged Excision: A Case Series.

Authors:  Daniel Garcia; Robert E Eilers; S Brian Jiang
Journal:  J Clin Investig Dermatol       Date:  2017-02-27

10.  Clinical size is a poor predictor of invasion in melanoma of the lentigo maligna type.

Authors:  Cristian Navarrete-Dechent; Saud Aleissa; Karen Connolly; Brian P Hibler; Stephen W Dusza; Anthony M Rossi; Erica Lee; Kishwer S Nehal
Journal:  J Am Acad Dermatol       Date:  2020-10-20       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.